Dataset Information


Gene expression profiling of anti-human VEGF-treated tumor xenografts formed by IGROV-1 or SKOV3 cells

ABSTRACT: This microarray experiment was designed to identify genes and pathways modulated in ovarian cancer xenografts treated with anti-human VEGF mAb (Bevacizumab). Tumors were established in NOD/SCID mice by s.c. injection of human ovarian cancer cells (IGROV-1 and SKOV3). Mice were treated with the anti-VEGF monoclonal antibody Bevacizumab or with PBS (control). Total RNA was extracted from tumor samples and hybridized on Affymetrix GeneChip™ PrimeView™ Human Gene Expression Arrays. Each sample was derived from a different mouse (n=5 mice/group). In order to evaluate the effects of the anti-human VEGF mAb in the two models, expression data of IGROV-1 and SKOV3 derived tumors were normalized and analyzed separately. Raw microarray data, preprocessed data matrix and results of differential expression analysis are available together with the applied protocols.

ORGANISM(S): Homo sapiens  

SUBMITTER: Carolina Venturoli   Angela Grassi   Stefano Indraccolo  Matteo Curtarello 

PROVIDER: E-MTAB-7683 | ArrayExpress | 2019-12-16


altmetric image


Anti-angiogenic therapy triggers metabolic alterations in experimental and human tumors, the best characterized being exacerbated glycolysis and lactate production. By using both Liquid Chromatography-Mass Spectrometry (LC-MS) and Nuclear Magnetic Resonance (NMR) analysis, we found that treatment of ovarian cancer xenografts with the anti-Vascular Endothelial Growth Factor (VEGF) neutralizing antibody bevacizumab caused marked alterations of the tumor lipidomic profile, including increased level  ...[more]

Similar Datasets

2014-04-25 | E-GEOD-37956 | ArrayExpress
2014-04-25 | E-GEOD-39413 | ArrayExpress
2014-04-25 | E-GEOD-39223 | ArrayExpress
| GSE39221 | GEO
2015-08-19 | E-GEOD-39413 | ExpressionAtlas
2015-08-19 | E-GEOD-39223 | ExpressionAtlas
2013-12-01 | E-GEOD-48880 | ArrayExpress
| GSE59476 | GEO
2013-07-01 | E-GEOD-45161 | ArrayExpress
| GSE20521 | GEO